Literature DB >> 8623540

Deletion of glycoprotein gE reduces the propagation of pseudorabies virus in the nervous system of mice after intranasal inoculation.

N Babic1, B Klupp, A Brack, T C Mettenleiter, G Ugolini, A Flamand.   

Abstract

A pseudorabies virus (PrV) mutant, deficient in the nonessential glycoprotein E (gE) and expressing the LacZ gene (gE- beta gal+ PrV), and its rescued virus were inoculated intranasally in mice. The median lethal dose of gE- beta gal+ PrV was similar to that of the parental Kaplan strain, but mice survived longer and did not develop symptoms of pseudorabies. In the nasal mucosa, gE- beta gal+ PrV replicated less efficiently than rescued virus. gE- beta gal+ PrV could infect first-order trigeminal and sympathetic neurons innervating the nasal mucosa. However, transneuronal transfer to second-order cells groups did not occur in trigeminal pathways and was severely reduced in sympathetic pathways. The mutant was also unable to propagate in the parasympathetic system. In contrast, gE-rescued virus was transferred transneuronally in trigeminal, sympathetic, and parasympathetic pathways, like wild-type PrV. These findings provide further evidence that deletion of gE specifically affects transneuronal transfer of PrV more than penetration and multiplication of the virus in first-order neurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623540     DOI: 10.1006/viro.1996.0247

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  45 in total

1.  Role of the pseudorabies virus gI cytoplasmic domain in neuroinvasion, virulence, and posttranslational N-linked glycosylation.

Authors:  R S Tirabassi; L W Enquist
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease.

Authors:  C E Saldanha; J Lubinski; C Martin; T Nagashunmugam; L Wang; H van Der Keyl; R Tal-Singer; H M Friedman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Glycoproteins gM and gN of pseudorabies virus are dispensable for viral penetration and propagation in the nervous systems of adult mice.

Authors:  M J Masse; A Jöns; J M Dijkstra; T C Mettenleiter; A Flamand
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Herpes simplex virus glycoproteins gD and gE/gI serve essential but redundant functions during acquisition of the virion envelope in the cytoplasm.

Authors:  Aaron Farnsworth; Kimberly Goldsmith; David C Johnson
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 5.  Herpesvirus transport to the nervous system and back again.

Authors:  Gregory Smith
Journal:  Annu Rev Microbiol       Date:  2012-06-15       Impact factor: 15.500

6.  Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking.

Authors:  S Mallory; M Sommer; A M Arvin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Neuron-to-cell spread of pseudorabies virus in a compartmented neuronal culture system.

Authors:  T H Ch'ng; L W Enquist
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Insertions in the gG gene of pseudorabies virus reduce expression of the upstream Us3 protein and inhibit cell-to-cell spread of virus infection.

Authors:  G L Demmin; A C Clase; J A Randall; L W Enquist; B W Banfield
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  The absence of glycoprotein gL, but not gC or gK, severely impairs pseudorabies virus neuroinvasiveness.

Authors:  A Flamand; T Bennardo; N Babic; B G Klupp; T C Mettenleiter
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  The UL7 gene of pseudorabies virus encodes a nonessential structural protein which is involved in virion formation and egress.

Authors:  Walter Fuchs; Harald Granzow; Robert Klopfleisch; Barbara G Klupp; Daniela Rosenkranz; Thomas C Mettenleiter
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.